Further, the recent study by Ding et al has shown that the treatment of Helicobacter-infected mice with recombinant IL-12 (which induces IFN-γ production by T cells) results in enhanced gastritis and reduced bacterial loads compared with untreated mice [31]. The gene discussed is IFNG; the disease is gastritis.